Table 2. Baseline characteristics for our cohort.
| Variable | Overall |
|---|---|
| Age, (years) | 58.5±10.3 |
| Male, n (%) | 7,446 (76.92) |
| Body mass index (kg/m2) | 24.53±4.46 |
| Systolic blood pressure (mmHg) | 127.1±17 |
| Diastolic blood pressure (mmHg) | 77.5±10.8 |
| Hypertension, n (%) | 6,254 (64.61) |
| Hyperlipidemia, n (%) | 6,502 (67.17) |
| Diabetes, n (%) | 2,936 (30.33) |
| Total cholesterol (mg/dL) | 4.2±1.1 |
| HDL-C (mg/dL) | 1±0.3 |
| BNP (pg/mL) | 756.9±584.4 |
| Serum creatinine (μmol/L) | 935±3,534.8 |
| Leukocyte (×109/L) | 6.8±1.7 |
| ESR (mm/h) | 10.9±11.6 |
| Big ET-1 (fmol/mL) | 0.3±0.2 |
| Hemoglobin (g/dL) | 143.1±15.4 |
| HbA1c (%) | 6.6±1.2 |
| hsCRP (pg/mL) | 3.1±3.7 |
| LVEF (%) | 62.8±7.3 |
| Smoking, n (%) | 5,531 (57.14) |
| Aspirin, n (%) | 9,556 (98.72) |
| Clopidogrel, n (%) | 9,529 (98.44) |
| Statin, n (%) | 9,287 (95.94) |
| All-cause death, n (%) | 467 (4.82) |
HDL-C, high-density lipoprotein cholesterol; BNP, B-type natriuretic peptide; ESR, erythrocyte sedimentation rate; Big ET-1, big endothelin-1; HbA1c, hemoglobin A1c; hsCRP, high sensitivity C-reactive protein; LVEF, left ventricular ejection fraction.